Quanterix Corporation Marketable Securities (Current)
Quanterix Corporation (QTRX) had Marketable Securities (Current) of $0 as of 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-03-17
- 2024-12-31: Marketable Securities, Current $0.00.
- 2023-12-31: Marketable Securities, Current $6.89M.
- 2022-12-31: Marketable Securities, Current $0.00.
| Period end | Marketable Securities, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2023-12-31 | $6.89M 10-K · filed 2025-03-17 |
| 2022-12-31 | $0.00 10-K/A · filed 2024-12-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |